Inotersen

Basic Information

Item Value
DrugBank ID DB14713
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 100

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 acute intermittent porphyria KG + DL
2 appendicitis KG + DL
3 IgG4-related pachymeningitis KG + DL
4 IgG4-related retroperitoneal fibrosis KG + DL
5 non-infectious meningitis KG + DL
6 peritonitis KG + DL
7 infectious meningitis KG + DL
8 IgG4-related mesenteritis KG + DL
9 IgG4-related mediastinitis KG + DL
10 IgG4-related aortitis KG + DL
11 eosinophilic angiocentric fibrosis KG + DL
12 chronic meningitis KG + DL
13 type I complement component 8 deficiency KG + DL
14 rheumatoid arthritis KG + DL
15 endocarditis KG + DL
16 IgG4-related hepatopathy KG + DL
17 porphyria KG + DL
18 endocardial fibroelastosis KG + DL
19 meningococcal infection KG + DL
20 pneumonia KG + DL
21 obsolete hyperuricemia (disease) KG + DL
22 hereditary persistence of fetal hemoglobin KG + DL
23 sclerosing cholangitis KG + DL
24 gout KG + DL
25 arachnoiditis KG + DL
26 meningitis (disease) KG + DL
27 colobomatous microphthalmia-rhizomelic dysplasia syndrome KG + DL
28 brachydactyly-syndactyly syndrome KG + DL
29 type II complement component 8 deficiency KG + DL
30 HIV infectious disease KG + DL
31 Lesch-Nyhan syndrome KG + DL
32 sickle cell anemia KG + DL
33 congestive heart failure KG + DL
34 scleroderma (disease) KG + DL
35 chronic hepatitis B virus infection KG + DL
36 bacterial arthritis KG + DL
37 hypouricemia, renal KG + DL
38 porphyria due to ALA dehydratase deficiency KG + DL
39 variegate porphyria KG + DL
40 suppurative cholangitis KG + DL
41 erythropoietic uroporphyria associated with myeloid malignancy KG + DL
42 acute pulmonary heart disease KG + DL
43 chronic hepatitis C virus infection KG + DL
44 intracranial abscess KG + DL
45 female breast carcinoma KG + DL
46 neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter KG + DL
47 infectious otitis media KG + DL
48 hereditary persistence of fetal hemoglobin-sickle cell disease syndrome KG + DL
49 sickle cell-hemoglobin c disease syndrome KG + DL
50 sickle cell-hemoglobin d disease syndrome KG + DL

(Showing top 50 of 100 predictions)

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). For research purposes only. Not medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.